FDA Determines Regulatory Review Period for INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially set a regulatory review period for the INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE, a medical device, in order to extend its patents, as required by law.